Clinical trial NCT04146766: Effectiveness of eHealth on the Self-management of Health Status and QOL Among CAD Patients
Official title: Effectiveness of eHealth on the Self-management, Physiological Health and Quality of Life Among Coronary Artery Disease Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: eHealth
Coronary Artery Disease
Quality of Life
Self-management
Keywords: Coronary artery disease
Remote Care
artificial intelligence
self-management
Quality of Life
Lead sponsor: National Defense Medical Center, Taiwan
Sponsor class: OTHER
First posted: 2019-10-31
Enrollment: 60
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: wait list control group RCT
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.

Detailed description: The World Health Organization points out that cardiovascular disease is the number one killer of global deaths, killing 17.1 million people worldwide each year, accounting for 31% of the world's total deaths. Heart disease is the second leading cause of death in China. Coronary artery disease (CAD) is the majority, and coronary artery disease is the most common cardiovascular disease. Good self-management can reduce disease risk factors and improve related prognosis. It is also an important issue in health promotion around the world. This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.

Eligibility criteria: Inclusion Criteria:

* A patient who is 20 years of age or older and has a Coronary computed tomography angiography \>50% vascular stenosis, has been PTCA、stent or CABG
* Taiwanese, understand Chinese

Exclusion Criteria:

* Those who can't express their wishes clearly (such as Azheimer's disease, mental dysfunction)
* mental disorder
* infectious diseases
* Patients who participate in other research projects

Primary outcomes:
measure: physiological indicators-HDL-C(T1)
timeFrame: T1-baseline
measure: physiological indicators-HDL-C(T2)
timeFrame: T2-three months later
measure: physiological indicators-HDL-C(T3)
timeFrame: T3-six months later
measure: physiological indicators-LDL-C(T1)
timeFrame: T1-baseline
measure: physiological indicators-LDL-C(T2)
timeFrame: T2-three months later
measure: physiological indicators-LDL-C(T3)
timeFrame: T3-six months later
measure: physiological indicators-Total Cholesterol(T1)
timeFrame: T1-baseline
measure: physiological indicators-Total Cholesterol(T2)
timeFrame: T2-three months later
measure: physiological indicators-Total Cholesterol(T3)
timeFrame: T3-six months later
measure: physiological indicators-Triglyceride(T1)
timeFrame: T1-baseline
measure: physiological indicators-Triglyceride(T2)
timeFrame: T2-three months later
measure: physiological indicators-Triglyceride(T3)
timeFrame: T3-six months later
measure: physiological indicators-GLU(T1)
timeFrame: T1-baseline
measure: physiological indicators-GLU(T2)
timeFrame: T2-three months later
measure: physiological indicators-GLU(T3)
timeFrame: T3-six months later
measure: physiological indicators-HbA1C(T1)
timeFrame: T1-baseline
measure: physiological indicators-HbA1C(T2)
timeFrame: T2-three months later
measure: physiological indicators-HbA1C(T3)
timeFrame: T3-six months later
Secondary outcomes:
measure: self-management-T1
timeFrame: T1-baseline
measure: self-management-T2
timeFrame: T2-three months later
measure: self-management-T3
timeFrame: T3-six months later
Other outcomes:
measure: Quality of life scale-T1
timeFrame: T1-baseline
measure: Quality of life scale-T2
timeFrame: T2-three months later
measure: Quality of life scale-T3
timeFrame: T3-six months later
measure: Modified Health care machine rating scale
timeFrame: T2-three months later
Locations:
city: Taipei city
country: Taiwan
facility: TSGH
Study officials:
References: